The “FRET Technology” brochure from
AnaSpec Inc. features the SensoLyte long-wavelength protease assay kits, which combine the company’s Förster resonance energy transfer (FRET) technology and peptide expertise. The 14-page downloadable document details SensoLyte kits for high-throughput screening of protease inhibitors or quantitation of renin, matrix metalloproteinases, α and
β secretases, angiotensin converting enzyme, and West Nile, hepatitis C and HIV. It includes a table of donor and acceptor molecules, a listing of dye-labeled amino acids and resins that can be used as building blocks, and guidelines on how to design FRET peptides.
To contact the manufacturer of this product,
click here.
To contribute to a discussion, you must be logged in.